Biliary absorption of dalbavancin: A prospective monocentric protocol in liver transplant recipients (DALBATRANS)

Infectious Diseases Now 2026 Open access

Read full text
Authors: Zakaria Maghlaoua, Agnès Bonadona, Saber Touati, Marion Le Maréchal, Mathilde Nicol, Pierre-Yves Eyraud, Capucine Arrivé, Françoise Stancke, Léa Abrial, Claire Berthault, Julien Ghelfi, Salomé Gallet
DOI: 10.1016/j.idnow.2026.105246
Cited by: 0
References: 15

Abstract

• We report the protocol of a pharmacokinetic prospective study. • This is the first study in humans to explore the biliary diffusion of dalbavancin. • We investigate dalbavancin to treat biliary infections in liver transplant patients.

Fields of Study & Subjects

Antibiotics Pharmacokinetics and Efficacy Drug Transport and Resistance Mechanisms Gallbladder and Bile Duct Disorders

Publication details

Journal / source
Infectious Diseases Now
Volume
56
Issue
2
Pages
105246–105246
Publication date
18 January 2026
Language
EN